Reuters logo
BRIEF-VBI Vaccines to present new preclinical data for its GBM immunotherapy, VBI-1901
2017年8月28日 / 下午1点19分 / 1 个月前

BRIEF-VBI Vaccines to present new preclinical data for its GBM immunotherapy, VBI-1901

Aug 28 (Reuters) - Vbi Vaccines Inc

* Vbi vaccines to present new preclinical data for its gbm immunotherapy, vbi-1901, at the immuno-oncology summit

* Vbi vaccines-co expects to initiate enrollment in multi-center phase i/2a clinical study evaluating vbi-1901 in patients with recurrent gbm in h2 2017 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below